Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Enrique Minguez

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Retina (Philadelphia, Pa.)|February 22, 2011
Diagnostic and therapeutic challengesFrancisco J Ascaso, Maria Rojo, Enrique Minguez, et al.
Journal of Ophthalmic Inflammation and Infection|June 24, 2015
Treatment of Acanthamoeba neurotrophic corneal ulcer with topical matrix therapyAntonio Mateo, Beatriz Abadía, Pilar Calvo, et al.
Ophthalmology|April 1, 2018
Successful Optimization of Adalimumab Therapy in Refractory Uveitis Due to Behçet's DiseaseJosé Luis Martín-Varillas, Vanesa Calvo-Río, Emma Beltrán, et al.
Rheumatology (Oxford, England)|July 6, 2014
Anti-TNF-α therapy in patients with refractory uveitis due to Behçet's disease: a 1-year follow-up study of 124 patientsVanesa Calvo-Río, Ricardo Blanco, Emma Beltrán, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 26, 2019
Comparative Study of Infliximab Versus Adalimumab in Refractory Uveitis due to Behçet's Disease: National Multicenter Study of 177 CasesBelén Atienza-Mateo, José Luis Martín-Varillas, Vanesa Calvo-Río, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Retina (Philadelphia, Pa.)|February 22, 2011
Diagnostic and therapeutic challengesFrancisco J Ascaso, Maria Rojo, Enrique Minguez, et al.
Journal of Ophthalmic Inflammation and Infection|June 24, 2015
Treatment of Acanthamoeba neurotrophic corneal ulcer with topical matrix therapyAntonio Mateo, Beatriz Abadía, Pilar Calvo, et al.
Ophthalmology|April 1, 2018
Successful Optimization of Adalimumab Therapy in Refractory Uveitis Due to Behçet's DiseaseJosé Luis Martín-Varillas, Vanesa Calvo-Río, Emma Beltrán, et al.
Rheumatology (Oxford, England)|July 6, 2014
Anti-TNF-α therapy in patients with refractory uveitis due to Behçet's disease: a 1-year follow-up study of 124 patientsVanesa Calvo-Río, Ricardo Blanco, Emma Beltrán, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 26, 2019
Comparative Study of Infliximab Versus Adalimumab in Refractory Uveitis due to Behçet's Disease: National Multicenter Study of 177 CasesBelén Atienza-Mateo, José Luis Martín-Varillas, Vanesa Calvo-Río, et al.
Pageof 1